Welcome to LookChem.com Sign In|Join Free
  • or
2-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

88371-29-3

Post Buying Request

88371-29-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88371-29-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 88371-29-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,3,7 and 1 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 88371-29:
(7*8)+(6*8)+(5*3)+(4*7)+(3*1)+(2*2)+(1*9)=163
163 % 10 = 3
So 88371-29-3 is a valid CAS Registry Number.

88371-29-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-oxo-3,4-dihydro-1H-quinoline-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1,2,3,4-tetrahydro-2-oxoquinoline-5-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88371-29-3 SDS

88371-29-3Relevant academic research and scientific papers

Enantioselective [4+2]-Cycloaddition Reaction of a Photochemically Generated o-Quinodimethane: Mechanistic Details, Association Studies, and Pressure Effects

Grosch, Benjamin,Orlebar, Caroline N.,Herdtweck, Eberhardt,Kaneda, Masayuki,Wada, Takehiko,Inoue, Yoshihisa,Bach, Thorsten

, p. 2179 - 2189 (2007/10/03)

1,2,3,4-Tetrahydro-2-oxoquinoline-5-aldehyde (2) was prepared from m-aminobenzoic acid and 3-ethoxyacryloyl chloride (4) in 19% overall yield. Compound 2 underwent a photochemically induced [4+2]-cyclo-addition reaction with various dienophiles upon irradiation in toluene solution. The exo product 10 a was obtained with acrylonitrile (9a) as the dienophile, whereas methyl acrylate (9b) and dimethyl fumarate (9c) furnished the endo products 11b and 11c (69-77% yield). The reactions proceeded at -60°C in the presence of the chiral complexing agent 1 (1.2 equiv) with excellent enantioselectivity (91-94% ee). The enantiomeric excess increases in the course of the photocycloaddition as a result of the lower product association to 1. The intermediate (E)-dienol 8 was spectroscopically detected at -196°C in an EPA (diethyl ether/isopentane/ethanol) glass matrix. The association of the substrate 2 to the complexing agent 1 was studied by circular dichroism (CD) titration. The measured association constant (KA) was 589 M-1 at room temperature (25°C) and normal pressure (0.1 MPa). An increase in pressure led to an increased association. At 400 MPa the measured value of KA was 703 M-1. Despite the stronger association the enantioselectivity of the reaction decreased with increasing pressure. At 25°C the enantiomeric excess for the enantioselective reaction 2 + 9a→10a decreased from 68% ee at 0.1 MPa to 58% ee at 350 MPa. This surprising behavior is explained by different activation volumes for the diastereomeric transition states leading to 10a and ent-10a.

Carbostyril derivatives

-

, (2008/06/13)

Disclosed are carbostyril derivatives and their salts of the formulas STR1 The compounds have anti-peptic ulcer effects, and are useful as a treating agent for curing peptic ulcers in the digestive system, such as ulcers in the stomach and in the duodenum. The compounds particularly have prophylaxis and curing effects for treating chronic ulcers, for example experimental acetic acid-induced ulcers and cautery ulcers, with both low toxicity and few side-effects. Also disclosed are processes for preparing the compounds and for preparing pharmaceutical compositions containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 88371-29-3